ArticlePediatric blood & cancer2021

Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.

Sarah B Whittle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.